Spark Therapeutics, Inc. — Form D

Spark Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-06-06. The offering totals $72.8M, of which $72.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2014-06-06
• Form: D
• Accession: 0001609351-14-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $72.8M
• Amount sold: $72.8M
• Investors: 28
• Date of first sale: 2014-05-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-218710

Issuer

• Name: Spark Therapeutics, Inc.
• CIK: 0001609351
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2013
• Address: 3501 CIVIC CENTER BOULEVARD, PHILADELPHIA, PA, 19104
• Phone: 888-772-7560

Officers, directors & promoters (9)

More

• CIK 1609351 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search